Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.
Other companies in Belite Bio’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Rapport Therapeutics (NASDAQ:RAPP).
Belite Bio has a consensus price target of $50.50.
The stock price for Belite Bio (NASDAQ: BLTE) is $68.18 last updated October 30, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Belite Bio.
Belite Bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Belite Bio.
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.